openPR Logo
Press release

Respiratory Inhalers Market Segments, Key Players Strategies, Analysis and Forecasts Till 2023

12-26-2017 07:32 PM CET | Health & Medicine

Press release from: Market Research Future

/ PR Agency: Market Research Future
Respiratory Inhalers Market

Respiratory Inhalers Market

The Global Respiratory Inhalers Market report titled “Respiratory Inhalers Market Research Report-Forecast to 2023″ is a specialist investigation report by Market Research Future includes broad essential research alongside the definite examination of subjective and additionally quantitative perspectives by different industry specialists, key sentiment pioneers to pick up a more profound understanding of the market and industry execution. Globally the market for respiratory inhaler is expected to grow at the rate of about 6.1% from 2017 to 2023.

GET SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/3110 .

Market Research Future published new report, titled “Respiratory Inhalers Market -Research Report: Global Forecast to 2023”.

Global Respiratory Inhaler Market Players:
The major participants of this market are Adherium limited, AstraZeneca, Boehringer Ingelheim GmbH, Chiesi Farmaceutici S.p.A., GSK plc, Propeller Health, and Teva Pharmaceutical Industries Ltd.

“AstraZeneca PLC Announces US FDA Accepts Regulatory Submission for Tagrisso in 1st-Line EGFR-Mutated Non-Small Cell Lung Cancer, Dec-18-17” AstraZeneca announced that the US Food and Drug Administration has accepted a supplemental New Drug Application for the use of Tagrisso (osimertinib), a third-generation, irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) with clinical activity against central nervous system (CNS) metastases, in the 1st-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumours have EGFR mutations (exon 19 deletions or exon 21 (L858R) substitution mutations).

“Adherium Limited Announces Earnings Results for the First Quarter Ended September 30, 2017; Provides Revenue Guidance for the Full Year Fiscal 2018” Adherium Limited announced earnings results for the first quarter ended September 30, 2017. For the quarter, the company reported total operating cash outflows of AUD 4.0 million against AUD 2.8 million a year ago. Revenues for the quarter were AUD 600,000. The company is on track to reach its previously stated full year fiscal 2018 guidance of revenue in the range of AUD 5.7 million to AUD 7 million.

“Boehringer Ingelheim Presents at New England Venture Summit 2017, Dec-06-2017.” Venue: Lombardo’s Conference Center, 6 Billings Street, Boston, Massachusetts, United States. Speakers: Martin Heidecker.

Market Highlights of Global Respiratory Inhalers Market:
The global respiratory inhaler market has been evaluated as steadily growing market and expected that the market will reach high growth figures. Respiratory inhalers are the devices which are used to control the respiratory conditions by directly inhaling the drug into the respiratory tract. Over the past 50 years, inhaler devices have revolutionized the respiratory care by delivering the medicines directly into the lungs and avoiding the adverse effects caused by the other modes of medication. However there has been a point of concern for the doctors whether the patients are talking the medication correctly or not. Because, even if you have the most potent drug in the inhaler; if the patient does not take the medication correctly and on time, you will not see the desired effect of the drug. Different inhaler drugs are being developed for the different conditions and the inhalers are prescribed to the patients on the basis of the condition of the patient and the severity of the disease. There are some major factors that are driving the market growth such as rising prevalence of respiratory disorders due to increase pollution and unhealthy lifestyle, increasing usage of combination therapies due to associated benefits such as more reliable in complex patients, increased efficacy and easy reimbursement policies associated with them and others.

On the other hand, there are some hindering factors which are restricting the market growth such as side effects and complications during inhalation, high prices of devices, and lack of accuracy etc. The market is expected to show large opportunities in the coming future with the advancement of technology in developing countries and new products with increased accuracy. However, some of the challenges which the market is expected to face includes competition from new entrants or big pharmaceutical giants entering the business or market and the continuous advancements in the product.

GET FULL REPORT @ https://www.marketresearchfuture.com/reports/respiratory-inhalers-market-3110 .

Regional Analysis of Global Respiratory Inhalers Market:
Depending on geographic region, Respiratory Inhaler market is segmented into four key regions: North America, Europe, Asia Pacific, and Middle East & Africa. Globally North America is the largest market for Respiratory Inhalers. The North America market for Respiratory Inhalers is expected to reach at USD 11,949.4 million by the end of the forecasted period. Europe is the second-largest market for respiratory inhalers which is expected to grow at a CAGR of 6.4%. Asia pacific region is expected to be fastest growing region in respiratory Inhaler market. Middle East & Africa is expected to have limited but steady growth in the market.

Market Segmentation:
Respiratory Inhalers market has been segmented on the basis of type which comprises of manually operated, digitally operated. Manually operated inhalers accounted for the largest market share of the total market in 2016. On the basis of product, the market is segmented into dry powder inhaler, metered dose inhaler, and others. Dry powder inhalers accounted for the largest market share in 2016. On the basis of application, market is segmented into asthma, COPD, and other. Asthma segment accounted for the largest market share of the total market in 2016. On the basis of end user, market is segmented into hospitals & clinics, respiratory care center, and other. Hospitals & clinics dominated the global market with the largest market share of the total market in 2016.

MAJOR TABLE OF CONTENTS:
Chapter 1. Report Prologue

Chapter 2. Introduction

Chapter 3. Research Methodology

Chapter 4. Market Dynamics

Chapter 5. Market Factor Analysis

Chapter 6. Global Respiratory Inhalers Market, By Type

Chapter 7. Global Respiratory Inhalers Market, By Product

Chapter 8. Global Respiratory Inhalers Market, By Application

Chapter 9. Global Respiratory Inhalers Market, By End User

Chapter 10. Global Respiratory Inhalers Market, By Region

Chapter 11. Competitive Landscape

Chapter 12. Company Profiles

Chapter 13. LIST OF TABLES
TABLE 1 Global Respiratory Inhalers Market, By Type, 2014-2023 (USD Million)
TABLE 2 Global Manually Operated Inhaler Market, By Region, 2014-2023 (USD Million)
TABLE 3 Global Digitally Operated Inhaler Market, By Region, 2014-2023 (USD Million)
TABLE 4 Global Respiratory Inhalers Market, By Product, 2014-2023 (USD Million)
TABLE 5 Global Dry Powder Inhaler Market, By Region, 2014-2023 (USD Million)

Chapter 14. LIST OF FIGURES
FIGURE 1 Global Respiratory Inhaler Market Share, By Type, 2016 (%)
FIGURE 2 Global Respiratory Inhaler Market Share, By Product, 2016 (%)
FIGURE 3 Global Respiratory Inhaler Market Share, By Application, 2016 (%)
FIGURE 4 Global Respiratory Inhaler Market Share, By End User, 2016 (%)
FIGURE 5 Global Respiratory Inhaler Market Share, By Region, 2016 (%)

…CONTINUED

GET DISCOUNT @ https://www.marketresearchfuture.com/check-discount/3110.

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:
Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Respiratory Inhalers Market Segments, Key Players Strategies, Analysis and Forecasts Till 2023 here

News-ID: 876013 • Views:

More Releases from Market Research Future

1 Hexene Market size, Scope, Growth Opportunities, Trends by Manufacturers and Forecast to 2032
1 Hexene Market size, Scope, Growth Opportunities, Trends by Manufacturers and F …
1-Hexene, a key chemical intermediate primarily used in the production of polyethylene, is experiencing a significant surge in demand globally. This demand is driven by several factors, including the growing need for high-density polyethylene (HDPE) and linear low-density polyethylene (LLDPE) in various industries such as packaging, construction, and automotive. The 1 Hexene Market is estimated at US$ 0.142 billion in 2024 and is forecasted to increase rapidly at a CAGR of
Hydroxypropyl Methylcellulose Capsules Market Surge to Witness Huge Demand at a CAGR of 9.40% during the forecast period 2032
Hydroxypropyl Methylcellulose Capsules Market Surge to Witness Huge Demand at a …
Hydroxypropyl Methylcellulose (HPMC) capsules are a popular choice in the pharmaceutical and nutraceutical industries due to their versatility, safety, and stability. These capsules are derived from cellulose, a natural polymer, and are widely used for encapsulating a variety of drugs, supplements, and vitamins. The HPMC capsules market has been experiencing steady growth over the years, driven by several key factors. Hydroxypropyl Methylcellulose Capsules Market was valued at USD 0.420 Billion in
Skincare Market Size, Share, Trends, Analysis, Demand 2023-2032
Skincare Market Size, Share, Trends, Analysis, Demand 2023-2032
The Skincare Market was valued at USD 7.15 Billion in 2022. It is forecasted to increase from USD 7.54 Billion in 2023 to USD 11.58 Billion by 2032, demonstrating a compound annual growth rate (CAGR) of 5.51% between 2023 and 2032. The comprehensive scope and research methodology of the Skincare Market report lay the foundation for a detailed and insightful analysis of the industry. The report's scope encompasses a broad spectrum,
Acesulfame Potassium Market Trends, Recent Developments and Technology, Size, Share, Future Growth, Forecast Research Report 2032 
Acesulfame Potassium Market Trends, Recent Developments and Technology, Size, Sh …
The wire and cable material market is a vital sector of the global economy, serving as the backbone for various industries, including telecommunications, energy, automotive, and construction. The market encompasses a wide range of materials used in the production of wires and cables, such as copper, aluminum, polymers, and insulating materials. Over the years, the market has witnessed significant evolution driven by technological advancements, regulatory changes, and shifting consumer preferences. The

All 5 Releases


More Releases for Inhaler

Increasing Number Of Launches In Generic Version Of Budesonide Inhaler Drive The …
Budesonide is an artificial glucocorticoid steroid related to the naturally-occurring hormone, cortisol or hydrocortisone, which is produced in the adrenal glands. It is used for treating asthma. Budesonide is sold under the brand name Pulmicort. Each budesonide inhaler is designed to provide 60 to 120 inhalations depending on the device. Increasing air population is expected to lead to high prevalence of asthma worldwide. According to World Health Organization (WHO), asthma
Global Digital Dose Inhaler Market Insights, Forecast
Digital Dose Inhaler is a kind of medical instrument. Digital Dose Inhaler enable patients to the number of tracking has consumed doses. The global Digital Dose Inhaler market is valued at 1790 million US$ in 2018 and will reach 3540 million US$ by the end of 2025, growing at a CAGR of 8.9% during 2019-2025. The objectives of this study are to define, segment, and project the size of the
Global Inhaler Market Research and Forecast 2018-2023
“Inhalers- a faster and better way to deliver respiratory medication” Orion Market Research (OMR) recently published a market research report on global inhaler market. It is forecasted that the market is augmenting with a significant CAGR during forecast period 2018-2023. The market is augmenting due to rising prevalence of respiratory disease, increasing air pollution and number of smokers. The global inhaler market is segmented by device, type, application and end-user. The
Dry Powder Inhaler Market Report 2018: Segmentation by Product (Single Dose Dry …
Global Dry Powder Inhaler market research report provides company profile for Astrazeneca Plc., 3M Company, GlaxoSmithKline Plc, Novartis AG, Cipla Ltd., Teva Pharmaceutical Industries Limited, Boehringer Ingelheim GmbH, Chiesi Farmaceutici S.p.A., MannKind Corporation and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and
The Inhaler Devices has Driven The Market for Global Asthma Inhaler Device Marke …
Market Research Future published a Half - Cooked research report on “Global Asthma Inhaler Device Market Research Report- Forecast To 2022” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2022. Adherium limited, AstraZeneca, Boehringer Ingelheim GmbH, Chiesi Farmaceutici S.p.A., GSK plc, Propeller Health, and Teva Pharmaceutical Industries Ltd. and others are some of the prominent players at the forefront of competition in the Global Asthma Inhaler Devices Market and
Asthma Inhaler Device Market by Metered Dose, Spacer and Dry Powder Type Inhaler …
The Worldwide Asthma Inhaler Device Market report provides various factors- price analysis, supply chain analysis, porters five force analysis etc. The report provides key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market Browse Complete 90 Pages Report enabled with Respective Tables and Figures is Available @ https://www.marketresearchfuture.com/reports/asthma-inhaler-device-market . Asthma is a type of inflammatory disease of the lungs. It